MedTrace Logo

Optical Coherence Tomography in Patients With Radiotherapy for Head and Neck Cancer

NCT04610645 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2026-03-03

No results posted yet for this study

Summary

The purpose of this study is to determine whether any eventual skin damage caused by radiation therapy can be detected and monitored at a subclinical level via optical coherence tomography (OCT). Another key question is whether subclinical OCT detected skin damage correlates with acute and late clinical toxicity.

Conditions

Interventions

DEVICE

OCT

3x3 OCT volume scans on treated and opposite side of the irreadiated area on head and neck

DEVICE

Dermatoscope

2x2 pictures taken with a dermatoscope

Sponsors & Collaborators

  • Verein zur Forschungsförderung der Krebshilfe OÖ

    collaborator UNKNOWN

  • RECENDT GmbH

    collaborator UNKNOWN

  • Johannes Kepler Universität Linz, Abteilung FLLL

    collaborator UNKNOWN

  • Universitätsklinikum Erlangen

    collaborator UNKNOWN

  • Andreas Fahl Medizintechnik-Vertrieb GmbH

    collaborator UNKNOWN

  • Krankenhaus Barmherzige Schwestern Linz

    lead OTHER

Principal Investigators

  • Hans Geinitz, Prim. Univ.-Prof. Dr. · Ordensklinikum Linz GmbH Barmherzige Schwestern (Dept. Radiooncology)

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-08
Primary Completion
2024-12-08
Completion
2025-04-08

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04610645 on ClinicalTrials.gov